News

Takeda Launches Three New Diabetes Treatments

Takeda has launched three new diabetes treatments: Nesina (alogliptin), Kazano (alogliptin and metformin HCl), and Oseni (alogliptin and pioglitazone).

Rate of Rheumatoid Arthritis Remission Down for Overweight Patients

For patients with early rheumatoid arthritis, being overweight or obese is associated with an increased likelihood of not achieving remission.

Rheumatoid Arthritis Patients Discontinue Meds at Median of Two Years

For patients with rheumatoid arthritis, the median time to discontinuation of therapy is 25.1 months, with longer time to discontinuation noted for those receiving tumor necrosis factor inhibitors.

Skipping Breakfast Tied to Insulin Resistance in Overweight Women

In overweight or obese women, missing breakfast is associated with insulin resistance.

Racial Differences Seen in Use of Pediatric Specialty Care in Autism

There are considerable racial and ethnic differences in the use of specialty care and procedures among children diagnosed with autism.

Early Neonatal Weight Gain Linked to Children's IQ

Gains in neonatal weight and head circumference in the first four weeks of life correlate with children's IQ at early school-age.

Sibling Aggression Linked to Mental Health Distress

Sibling aggression has a detrimental effect on children's and adolescents' mental health.

Initiating Statins Linked to Increased Risk of T2DM

Initiating statin therapy is associated with an increased risk of type 2 diabetes, which is not explained by differential survival.

Neurological Testing Limited in Diagnosing Disc Herniation

Neurological testing procedures have limited diagnostic accuracy for detecting disc herniation with suspected radiculopathy.

Adrenaclick Auto-Injector Available Again for Anaphylaxis

Amedra announced the relaunch of Adrenaclick (epinephrine) auto-injector for the emergency treatment of anaphylaxis.